Paper

Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo

Published Jun 1, 2010 · C. Heurteaux, C. Gandin, M. Borsotto

Neuropharmacology

116

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCTAnimal StudyHighly Cited

Study Snapshot

NeuroAid (MLC601) and MLC901 treatments improve survival, protect the brain from ischemic injury, and decrease functional deficits in stroke patients.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo

References

Citations